Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 183

1.

Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage.

Iqbal S, Li R, Gargiullo P, Vellozzi C.

Vaccine. 2015 Apr 21;33(17):2045-9. doi: 10.1016/j.vaccine.2015.02.064. Epub 2015 Mar 4.

PMID:
25749247
2.

In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases.

McGarvey PB, Suzek BE, Baraniuk JN, Rao S, Conkright B, Lababidi S, Sutherland A, Forshee R, Madhavan S.

BMC Immunol. 2014 Dec 9;15(1):61. [Epub ahead of print]

3.

Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.

Ropero-Álvarez AM, Whittembury A, Bravo-Alcántara P, Kurtis HJ, Danovaro-Holliday MC, Velandia-González M.

Vaccine. 2015 Jan 1;33(1):187-92. doi: 10.1016/j.vaccine.2014.10.070. Epub 2014 Nov 6.

4.

Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events.

Nordin JD, Kharbanda EO, Vazquez-Benitez G, Lipkind H, Lee GM, Naleway AL.

Vaccine. 2014 Sep 3;32(39):4985-92. doi: 10.1016/j.vaccine.2014.07.017. Epub 2014 Jul 18.

PMID:
25045808
5.

Neurological events related to influenza A (H1N1) pdm09.

Cárdenas G, Soto-Hernández JL, Díaz-Alba A, Ugalde Y, Mérida-Puga J, Rosetti M, Sciutto E.

Influenza Other Respir Viruses. 2014 May;8(3):339-46. doi: 10.1111/irv.12241. Review.

6.

Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany.

Prestel J, Volkers P, Mentzer D, Lehmann HC, Hartung HP, Keller-Stanislawski B; GBS Study Group.

Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1192-204. doi: 10.1002/pds.3638. Epub 2014 May 10.

7.

Influenza vaccination and Guillain-Barré syndrome.

Kwong JC, Crowcroft NS, Wilson K, McGeer AJ, Deeks SL.

Lancet Infect Dis. 2014 May;14(5):369-70. doi: 10.1016/S1473-3099(14)70716-9. No abstract available.

PMID:
24758991
8.

Influenza vaccination and Guillain-Barré syndrome.

Giovanetti F.

Lancet Infect Dis. 2014 May;14(5):368. doi: 10.1016/S1473-3099(14)70714-5. No abstract available.

PMID:
24758990
9.

Influenza vaccination and Guillain-Barré syndrome.

Wiznitzer M.

Lancet Infect Dis. 2014 May;14(5):368-9. doi: 10.1016/S1473-3099(14)70715-7. No abstract available.

PMID:
24758989
10.

Influenza vaccinations and chemosensory function.

Doty RL, Berman AH, Izhar M, Hamilton HB, Villano D, Vazquez BE, Warrum MN, Mahbob M.

Am J Rhinol Allergy. 2014 Jan-Feb;28(1):50-3. doi: 10.2500/ajra.2014.28.3987.

PMID:
24717882
11.

Immunogenicity and safety of a trivalent inactivated 2010-2011 influenza vaccine in Taiwan infants aged 6-12 months.

Hwang KP, Hsu YL, Hsieh TH, Lin HC, Yen TY, Wei HM, Lin HC, Chen AC, Chow JC, Huang LM.

Vaccine. 2014 May 1;32(21):2469-73. doi: 10.1016/j.vaccine.2014.02.078. Epub 2014 Mar 10.

PMID:
24625341
12.

Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.

Verity C, Stellitano L, Winstone AM, Stowe J, Andrews N, Miller E.

Arch Dis Child. 2014 Jun;99(6):532-8. doi: 10.1136/archdischild-2013-304475. Epub 2014 Feb 28.

PMID:
24585755
13.

Re: "Chart-confirmed Guillain-Barré syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010".

Stang A.

Am J Epidemiol. 2014 Mar 1;179(5):660. doi: 10.1093/aje/kwt434. No abstract available.

14.

Guillain-Barré syndrome in an older man following influenza vaccination.

Finch NA, Guarascio AJ, Suda KJ.

J Am Pharm Assoc (2003). 2014 Mar-Apr;54(2):188-92. doi: 10.1331/JAPhA.2014.13152.

PMID:
24531983
15.

Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.

Vellozzi C, Iqbal S, Stewart B, Tokars J, DeStefano F.

Am J Public Health. 2014 Apr;104(4):696-701. doi: 10.2105/AJPH.2013.301651. Epub 2014 Feb 13.

PMID:
24524517
16.

Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.

Kawai AT, Li L, Kulldorff M, Vellozzi C, Weintraub E, Baxter R, Belongia EA, Daley MF, Jacobsen SJ, Naleway A, Nordin JD, Lee GM.

Pharmacoepidemiol Drug Saf. 2014 May;23(5):548-53. doi: 10.1002/pds.3575. Epub 2014 Feb 4.

PMID:
24497128
17.

Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.

Vellozzi C, Iqbal S, Broder K.

Clin Infect Dis. 2014 Apr;58(8):1149-55. doi: 10.1093/cid/ciu005. Epub 2014 Jan 9.

18.

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.

Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, Arnheim-Dahlström L, Sparen P, Mosseveld M, Schuemie M, van der Maas N, Jacobs BC, Leino T, Kilpi T, Storsaeter J, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC.

PLoS One. 2014 Jan 3;9(1):e82222. doi: 10.1371/journal.pone.0082222. eCollection 2014.

19.

Guillain-Barré syndrome surveillance during National Influenza Vaccination Campaign, New York, U.S.A., 2009.

Giambrone GP, Zansky SM, Eidson M, Duncan PG, McNutt LA, Birkhead GS.

Emerg Infect Dis. 2013 Dec;19(12):1956-62. doi: 10.3201/eid1912.130643.

20.

Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice.

[No authors listed]

Prescrire Int. 2013 Sep;22(141):201-4.

PMID:
24171209
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk